Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin"s lymphoma: final results of the German Hodgkin"s Lymphoma Study Group Trial HD5.

Markus Sieber; Hans Tesch; Beate Pfistner; Ulrich Rueffer; Bernd Lathan; Oana Brosteanu; Ursula Paulus; Tina Koch; Michael Pfreundschuh; Markus Loeffler; Andreas Engert; Andreas Josting; Jürgen Wolf; Dirk Hasenclever; Jeremy Franklin; Eckhart Duehmke; Axel Georgii; Klaus-Peter Schalk; Hartmut Kirchner; Gottfried Doelken; Reinhold Munker; Peter Koch; Richard Herrmann; Richard Greil; Anna Paola Anselmo; Volker Diehl

doi:10.1200/JCO.20.2.476

Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin"s lymphoma: final results of the German Hodgkin"s Lymphoma Study Group Trial HD5.

Markus Sieber, Hans Tesch, Beate Pfistner, Ulrich Rueffer, Bernd Lathan, Oana Brosteanu, Ursula Paulus, Tina Koch, Michael Pfreundschuh, Markus Loeffler, Andreas Engert, Andreas Josting, Jürgen Wolf, Dirk Hasenclever, Jeremy Franklin, Eckhart Duehmke, Axel Georgii, Klaus-Peter Schalk, Hartmut Kirchner, Gottfried DoelkenReinhold Munker, Peter Koch, Richard Herrmann, Richard Greil (Co-author), Anna Paola Anselmo, Volker Diehl

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

38 Citations (Web of Science)

Original language	English
Pages (from-to)	476-484
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	20
Issue number	2
DOIs	https://doi.org/10.1200/JCO.20.2.476
Publication status	Published - 2002

Keywords

ADJUVANT RADIOTHERAPY
HYBRID CHEMOTHERAPY
COMBINED-MODALITY
DISEASE
MOPP
ABVD
IRRADIATION
REGIMEN
THERAPY

Access to Document

10.1200/JCO.20.2.476

Cite this

Sieber, M., Tesch, H., Pfistner, B., Rueffer, U., Lathan, B., Brosteanu, O., Paulus, U., Koch, T., Pfreundschuh, M., Loeffler, M., Engert, A., Josting, A., Wolf, J., Hasenclever, D., Franklin, J., Duehmke, E., Georgii, A., Schalk, K.-P., Kirchner, H., ... Diehl, V. (2002). Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin"s lymphoma: final results of the German Hodgkin"s Lymphoma Study Group Trial HD5. JOURNAL OF CLINICAL ONCOLOGY , 20(2), 476-484. https://doi.org/10.1200/JCO.20.2.476

Sieber, Markus ; Tesch, Hans ; Pfistner, Beate et al. / Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin"s lymphoma: final results of the German Hodgkin"s Lymphoma Study Group Trial HD5. In: JOURNAL OF CLINICAL ONCOLOGY 2002 ; Vol. 20, No. 2. pp. 476-484.

@article{985cd55b2ca74d1e97f9e9861d9d5290,

title = "Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin{"}s lymphoma: final results of the German Hodgkin{"}s Lymphoma Study Group Trial HD5.",

keywords = "ADJUVANT RADIOTHERAPY, HYBRID CHEMOTHERAPY, COMBINED-MODALITY, DISEASE, MOPP, ABVD, IRRADIATION, REGIMEN, THERAPY",

author = "Markus Sieber and Hans Tesch and Beate Pfistner and Ulrich Rueffer and Bernd Lathan and Oana Brosteanu and Ursula Paulus and Tina Koch and Michael Pfreundschuh and Markus Loeffler and Andreas Engert and Andreas Josting and J{\"u}rgen Wolf and Dirk Hasenclever and Jeremy Franklin and Eckhart Duehmke and Axel Georgii and Klaus-Peter Schalk and Hartmut Kirchner and Gottfried Doelken and Reinhold Munker and Peter Koch and Richard Herrmann and Richard Greil and Anselmo, {Anna Paola} and Volker Diehl",

year = "2002",

doi = "10.1200/JCO.20.2.476",

language = "English",

volume = "20",

pages = "476--484",

journal = "JOURNAL OF CLINICAL ONCOLOGY ",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins ",

number = "2",

}

Sieber, M, Tesch, H, Pfistner, B, Rueffer, U, Lathan, B, Brosteanu, O, Paulus, U, Koch, T, Pfreundschuh, M, Loeffler, M, Engert, A, Josting, A, Wolf, J, Hasenclever, D, Franklin, J, Duehmke, E, Georgii, A, Schalk, K-P, Kirchner, H, Doelken, G, Munker, R, Koch, P, Herrmann, R, Greil, R, Anselmo, AP & Diehl, V 2002, 'Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin"s lymphoma: final results of the German Hodgkin"s Lymphoma Study Group Trial HD5.', JOURNAL OF CLINICAL ONCOLOGY , vol. 20, no. 2, pp. 476-484. https://doi.org/10.1200/JCO.20.2.476

Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin"s lymphoma: final results of the German Hodgkin"s Lymphoma Study Group Trial HD5. / Sieber, Markus; Tesch, Hans; Pfistner, Beate et al.
In: JOURNAL OF CLINICAL ONCOLOGY , Vol. 20, No. 2, 2002, p. 476-484.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin"s lymphoma: final results of the German Hodgkin"s Lymphoma Study Group Trial HD5.

AU - Sieber, Markus

AU - Tesch, Hans

AU - Pfistner, Beate

AU - Rueffer, Ulrich

AU - Lathan, Bernd

AU - Brosteanu, Oana

AU - Paulus, Ursula

AU - Koch, Tina

AU - Pfreundschuh, Michael

AU - Loeffler, Markus

AU - Engert, Andreas

AU - Josting, Andreas

AU - Wolf, Jürgen

AU - Hasenclever, Dirk

AU - Franklin, Jeremy

AU - Duehmke, Eckhart

AU - Georgii, Axel

AU - Schalk, Klaus-Peter

AU - Kirchner, Hartmut

AU - Doelken, Gottfried

AU - Munker, Reinhold

AU - Koch, Peter

AU - Herrmann, Richard

AU - Greil, Richard

AU - Anselmo, Anna Paola

AU - Diehl, Volker

PY - 2002

Y1 - 2002

KW - ADJUVANT RADIOTHERAPY

KW - HYBRID CHEMOTHERAPY

KW - COMBINED-MODALITY

KW - DISEASE

KW - MOPP

KW - ABVD

KW - IRRADIATION

KW - REGIMEN

KW - THERAPY

U2 - 10.1200/JCO.20.2.476

DO - 10.1200/JCO.20.2.476

M3 - Original Article

C2 - 11786577

SN - 0732-183X

VL - 20

SP - 476

EP - 484

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 2

ER -

Sieber M, Tesch H, Pfistner B, Rueffer U, Lathan B, Brosteanu O et al. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin"s lymphoma: final results of the German Hodgkin"s Lymphoma Study Group Trial HD5. JOURNAL OF CLINICAL ONCOLOGY . 2002;20(2):476-484. doi: 10.1200/JCO.20.2.476